Australia's largest stock trading and investment forum Australia's #1 stock forum

RAP

Click for more information

0.00%

20.5¢ raptor resources limited

Ann: Pre-Submission package lodged with the US FDA, page-28

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 28 Last

Share
Profile

Follow
AlCp

27,119 Posts.

1755

10/02/21

12:09

Post #: 50856334
Share

Originally posted by Southoz ↑

AICp - page 4 of the protocol paper - in the section on statistical considerations.

The adjudication rates between the Aussie and US doctors were roughly equivalent. The reason for the slight difference will be due to study implementation.

In the Australian studies the researchers are the clinicians in the hospital and have the leverage (and care factor) to ensure high quality information is collected during the study period.

In the US there is a strict separation between clinical and research functions. And the researchers have little ability to influence the quality of information that clinicians produce in routine practice.

Poorer quality information will produce lower rates of adjudication agreement.

I appreciate AICp that as layperson this stuff is not simple to understand. But posting prolifically doesn't actually make you know anything better.

Expand

Hence my point that 33% of the disagreement had a factor of the accuracy in the US clinical trial compared to that done in Australia, can you provide the link to that paper, this accuracy wasn't mentioned in the primary outcome of the clinical trial.

Last edited by AlCp: 10/02/21

RAP Price at posting: 7.0¢ Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

MND

Monadelphous profits up 16.2% on strong revenue result, and the market likes it

CC9

Chariot locks in high-potential drill target at Black Mountain, one of the USA's largest lithium landholdings

KOB

Koba jumps on uranium rock chips grading over 7% as uranium price revival evidence mounts

SGQ

St George Mining jumps 8% on news it's appointed two niobium executives – from the world's biggest player, CBMM

IIQ

INOVIQ says it has found a way to test blood for Parkinson's Disease – after Alzheimer's success in June

There are more pages in this discussion • 172 more messages in this thread...

First 28 Last

Add RAP (ASX) to my watchlist